Cargando…
Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids
A 75-year-old female with no history of lung disease developed severe pulmonary fibrosis within 1 month of acute severe COVID-19 pneumonia. She developed dry basal crackles, hypoxia needing home oxygen, and computed tomography changes which dramatically evolved from acute ground-glass opacities to h...
Autores principales: | Udwadia, Zarir Farokh, Pokhariyal, Priyanka Kisan, Tripathi, Awatansh Kumar Rajkumar, Kohli, Anirudh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104339/ https://www.ncbi.nlm.nih.gov/pubmed/33686982 http://dx.doi.org/10.4103/lungindia.lungindia_533_20 |
Ejemplares similares
-
Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy
por: Udwadia, Zarir F., et al.
Publicado: (2022) -
Treating household contacts of MDR-TB patients: Are we being too hasty?
por: Udwadia, Zarir F., et al.
Publicado: (2023) -
The impact of COVID-19 on patients with preexisting interstitial lung disease: High mortality in these high-risk patients
por: Udwadia, Zarir Farokh, et al.
Publicado: (2021) -
COVID-19 -Tuberculosis interactions: When dark forces collide
por: Udwadia, Zarir F., et al.
Publicado: (2020) -
Why “covering all” in the DOTS program is not necessarily “all being covered” by the DOTS program
por: Pinto, Lancelot Mark, et al.
Publicado: (2010)